Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 96.70B | 95.57B | 88.42B | 102.30B | 101.20B | 86.67B |
Gross Profit | 21.38B | 21.25B | 21.07B | 22.69B | 21.89B | 20.14B |
EBITDA | 10.06B | 9.59B | 8.89B | 7.66B | 12.02B | 9.79B |
Net Income | 4.60B | 4.59B | 3.39B | 2.44B | 5.56B | 3.25B |
Balance Sheet | ||||||
Total Assets | 86.87B | 79.75B | 82.09B | 89.61B | 92.73B | 123.42B |
Cash, Cash Equivalents and Short-Term Investments | 7.70B | 3.63B | 7.37B | 8.88B | 10.01B | 10.34B |
Total Debt | 28.78B | 24.57B | 25.99B | 29.59B | 27.96B | 40.45B |
Total Liabilities | 89.89B | 81.13B | 84.40B | 92.64B | 94.31B | 115.39B |
Stockholders Equity | -3.02B | -1.48B | -2.23B | -3.12B | -1.69B | 2.95B |
Cash Flow | ||||||
Free Cash Flow | 3.65B | 1.87B | 5.92B | 562.00M | 7.51B | 9.32B |
Operating Cash Flow | 6.27B | 4.52B | 8.68B | 3.56B | 10.31B | 11.41B |
Investing Cash Flow | -1.85B | -2.21B | -2.78B | -3.02B | 1.31B | -460.00M |
Financing Cash Flow | -2.50B | -5.82B | -7.09B | -1.63B | -16.61B | -5.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $21.18B | 18.63 | 108.51% | 1.97% | 5.02% | 22.19% | |
77 Outperform | $28.40B | 27.05 | 21.03% | ― | 82.10% | 6.35% | |
70 Outperform | $84.17B | 19.77 | -179.12% | 1.69% | 7.68% | 27.73% | |
69 Neutral | ¥231.71B | 14.67 | 7.64% | 2.71% | 9.09% | 8.52% | |
63 Neutral | $22.08B | 12.17 | 28.45% | 0.16% | 21.22% | ― | |
61 Neutral | $23.27B | 9.55 | 84.33% | 4.67% | 2.08% | -12.41% | |
61 Neutral | $30.02B | 20.44 | -109.27% | 2.04% | 36.29% | ― |